Published in N Engl J Med on August 14, 1975
Crohn's disease and the mycobacterioses: a review and comparison of two disease entities. Clin Microbiol Rev (1989) 3.67
Evidence for a transmissible factor in Crohn's disease. Gut (1977) 0.89
A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis (2000) 6.90
The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) (1976) 4.81
Decrease in net stool output in cholera during intestinal perfusion with glucose-containing solutions. N Engl J Med (1968) 3.57
Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study. N Engl J Med (1980) 3.01
Reoperation and recurrence in Crohn's colitis and ileocolitis Crude and cumulative rates. N Engl J Med (1975) 2.59
Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut (1988) 2.51
Cancer in universal and left-sided ulcerative colitis: factors determining risk. Gastroenterology (1979) 2.48
The effect of localized injection of adjuvant material on the draining lymph node. II. Circulating lymphocytes. Immunology (1970) 2.19
The superior mesenteric artery syndrome. The disease that isn't, or is it? J Clin Gastroenterol (1985) 2.13
Segregation of lymphocyte populations through differential migration. Nature (1969) 2.09
The effect of localized injection of adjuvant material on the draining lymph node. I. Histology. Immunology (1970) 2.00
Notes on the preparation and assay of anti-lymphocytic serum for use in mice. Immunology (1968) 1.96
A comparison of cancer risk in Crohn's disease and ulcerative colitis. Cancer (1981) 1.83
Immunologic dysfunction in heroin addicts. Arch Intern Med (1974) 1.77
How effective are current drugs for Crohn's disease? A meta-analysis. J Clin Gastroenterol (1992) 1.75
Histopathological effects in mice of heterologous antilymphocyte serum. J Exp Med (1968) 1.61
Response of the normal and pathological human gastric mucosa to an instilled acid load. Gastroenterology (1968) 1.59
Fecal alpha 1-antitrypsin measurement: an indicator of Crohn's disease activity. Gastroenterology (1985) 1.53
Cluster of inflammatory bowel disease in three close college friends? J Clin Gastroenterol (1993) 1.52
Effects of heterologous anti-lymphocyte serum on the distribution of 51-Cr-labelled lymph node cells in mice. Immunology (1968) 1.52
Imparied lymphocyte responsiveness in inflammatory bowel disease. Gastroenterology (1973) 1.51
The effect of localized injection of adjuvant material on the draining lymph node. 3. Thymus dependence. J Immunol (1972) 1.48
Patterns of neoplasia in Crohn's disease and ulcerative colitis. Cancer (1980) 1.45
Architectural organization in the interphase nucleus of the protozoan Trypanosoma brucei: location of telomeres and mini-chromosomes. EMBO J (1990) 1.44
Cancer in Crohn's disease after diversionary surgery. A report of seven carcinomas occurring in excluded bowel. Am J Surg (1978) 1.44
Short-term lymphocyte cultures in regional enteritis. Lancet (1970) 1.43
Perpetuation of published medical errors. Lancet (1993) 1.43
Risk factors for postoperative recurrence of Crohn's disease. Gastroenterology (1983) 1.43
Granulomatous ileocolitis. Gut (1966) 1.42
Prostanoid synthesis by cultured intestinal epithelial and mononuclear cells in inflammatory bowel disease. Gut (1983) 1.42
Subcellular distribution of daunorubicin in P-glycoprotein-positive and -negative drug-resistant cell lines using laser-assisted confocal microscopy. Cancer Res (1991) 1.40
Sera-reactivity in inflammatory bowel disease: frequency of recognition of Crohn's disease tissue primed nude mouse lymphoid tissue in an interinstitutional blinded study. J Clin Gastroenterol (1989) 1.40
ACTH-induced adrenal hemorrhage: a complication of therapy masquerading as an acute abdomen. J Clin Gastroenterol (1990) 1.40
Anergy to dinitrochlorobenzene and depression of T-lymphocytes in Crohn's disease and ulcerative colitis. Gut (1976) 1.38
Glucose therapy in short-bowel syndrome. Lancet (1971) 1.36
Extraintestinal cancers in inflammatory bowel disease. Cancer (1985) 1.34
Recurrent regional ileitis after ileostomy and colectomy for granulomatous colitis. N Engl J Med (1972) 1.33
Intestinal transmural electric potential and its response to glucose in acute and convalescent cholera. Gastroenterology (1969) 1.27
Cutaneous vasculitis complicating coeliac disease. Gut (1981) 1.27
Is there Kveim responsiveness in Crohn's disease? Lancet (1971) 1.26
Effects of lymphoid depletion on the distribution of 51Cr-labeled lymph node cells in mice. Transplantation (1971) 1.23
Free perforation in Crohn's disease: I. A survey of 99 cases. Am J Gastroenterol (1985) 1.23
Trauma and the pyoderma gangrenosum of inflammatory bowel disease. Gut (1981) 1.22
Chronic portal-systemic encephalopathy after ileostomy and colonic resection. Lancet (1966) 1.22
Carcinoid tumor and inflammatory bowel disease: a study of eleven cases and review of the literature. Am J Gastroenterol (1997) 1.21
Granulomatous diseases of the gastrointestinal tract. Annu Rev Med (1966) 1.20
Olsalazine sodium in the treatment of ulcerative colitis among patients intolerant of sulfasalazine. A prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial. Gastroenterology (1987) 1.19
The role of the fecal stream in Crohn's disease: an historical and analytic review. Inflamm Bowel Dis (1998) 1.19
Tumor-associated (CEA-reacting) antigen in patients with inflammatory bowel disease. N Engl J Med (1972) 1.18
Obstructive hydronephrosis. A frequent but seldom recognized complication of granulomatous disease of the bowel. N Engl J Med (1969) 1.18
Granulomatous colitis--pathogenetic concepts. Gastroenterology (1966) 1.17
Occurrence of Clostridium difficile toxin during the course of inflammatory bowel disease. Gastroenterology (1981) 1.16
Inhibition by diphenylhydantoin of folic acid absorption in man. Gastroenterology (1972) 1.16
Colorectal cancer in ulcerative colitis. Influence of anatomical extent and age at onset on colitis-cancer interval. Gut (1991) 1.15
Distribution of labeled lymph node cells in mice during the lymphocytosis induced by Bordetella pertussis. J Exp Med (1972) 1.14
Benign and malignant colorectal strictures in ulcerative colitis. Gut (1992) 1.13
Influence of glucagon on pancreatic exocrine secretion. Gastroenterology (1969) 1.12
Effect of verapamil and other agents on the distribution of anthracyclines and on reversal of drug resistance. Cancer Res (1987) 1.11
Severe gastrointestinal hemorrhage in Crohn's disease. Ann Surg (1991) 1.11
Ulcerative colitis practice guidelines in adults. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol (1997) 1.11
Secretion of calcium by the canine pancreas. Gastroenterology (1967) 1.10
Granulomas do not affect postoperative recurrence rates in Crohn's disease. Gastroenterology (1982) 1.10
Intracellular distribution and pharmacokinetics of daunorubicin in anthracycline-sensitive and -resistant HL-60 cells. Cancer Res (1989) 1.09
A comparison of multiple synchronous colorectal cancer in ulcerative colitis, familial polyposis coli, and de novo cancer. Ann Surg (1986) 1.09
Neuroleptic malignant syndrome induced by domperidone. Dig Dis Sci (1992) 1.09
Erythrocytic sedimentation rate as a measure of clinical activity in inflammatory bowel disease. J Clin Gastroenterol (1986) 1.08
Spontaneous free perforation and perforated abscess in 30 patients with Crohn's disease. Ann Surg (1987) 1.08
Outcome of toxic dilatation in ulcerative and Crohn's colitis. J Clin Gastroenterol (1985) 1.07
T and B lymphocytes and cutaneous anergy in inflammatory bowel disease. Ann N Y Acad Sci (1976) 1.07
Clinical and colonoscopic surveillance in ulcerative colitis: are we saving colons or saving lives? Gastroenterology (1993) 1.06
The amylase-creatinine clearance ratio. Diagnostic parameter or physiologic phenomenon? Am J Gastroenterol (1974) 1.06
Chemotherapy for advanced sarcoma: therapeutic decisions and modalities. Semin Oncol (1997) 1.06
Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease. Aliment Pharmacol Ther (2011) 1.05
Mucosal blood flow in canine antral and fundic pouches. Gastroenterology (1971) 1.04
Surgical treatment, skin test reactivity, and lymphocytes in inflammatory bowel disease. Am J Surg (1983) 1.04
Lymphoma in inflammatory bowel disease. Cancer (1992) 1.03
Isolation and characterization of an anthracycline-resistant human leukemic cell line. Cancer Res (1985) 1.03
Effect of secretin and acetazolamide on the volume and electrolyte composition of hepatic bile in man. Gastroenterology (1969) 1.02
Role of glutathione and dependent enzymes in anthracycline-resistant HL60/AR cells. Cancer Res (1989) 1.02
Amyloidosis and inflammatory bowel disease. A 50-year experience with 25 patients. Medicine (Baltimore) (1992) 1.01
Predicting the outcome of corticoid therapy for acute ulcerative colitis. Results of a prospective, randomized, double-blind clinical trial. J Clin Gastroenterol (1987) 1.00